Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
RVNC

Revance

$25.85

1.1 (4.44%)

04:55
06/22/17
06/22
04:55
06/22/17
04:55
Conference/Events
Revance management to meet with William Blair »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

Yesterday
RVNC

Revance

07:12
06/21/17
06/21
07:12
06/21/17
07:12
Conference/Events
Revance management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

  • 22

    Jun

RVNC

Revance

07:07
06/21/17
06/21
07:07
06/21/17
07:07
Conference/Events
Revance management to meet with William Blair »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

Over a week ago
RVNC

Revance

$22.95

-0.25 (-1.08%)

08:12
06/15/17
06/15
08:12
06/15/17
08:12
Hot Stocks
Revance BELMONT Phase 2 trial results published in Dermatologic Surgery »

Revance Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

RVNC

Revance

$24.25

-0.65 (-2.61%)

16:07
06/05/17
06/05
16:07
06/05/17
16:07
Hot Stocks
Revance reports additional 'positive' week 24 efficacy results from RT002 trial »

Revance Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

Over a month ago
RVNC

Revance

$19.35

0.25 (1.31%)

07:49
05/19/17
05/19
07:49
05/19/17
07:49
Recommendations
Revance analyst commentary at SunTrust »

Revance data positive, …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

RVNC

Revance

$19.35

0.25 (1.31%)

16:24
05/18/17
05/18
16:24
05/18/17
16:24
Conference/Events
Revance to hold a conference call »

Management discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

RVNC

Revance

$19.35

0.25 (1.31%)

16:06
05/18/17
05/18
16:06
05/18/17
16:06
Hot Stocks
Revance announces 'positive' top-line results in RT002 cohorts study »

Revance Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

RVNC

Revance

$20.30

1 (5.18%)

17:05
05/09/17
05/09
17:05
05/09/17
17:05
Hot Stocks
Revance backs FY17 cash burn view $102M-$112M »

Backs FY17 operating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 06

    Jun

RVNC

Revance

$20.30

1 (5.18%)

17:04
05/09/17
05/09
17:04
05/09/17
17:04
Earnings
Revance reports Q1 EPS (94c), consensus (85c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 06

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.